Novel process of intrathymic tumor-immune tolerance through CCR2-mediated recruitment of Sirpα+ dendritic cells: A murine model

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Baba, Tomohisa ^a   Badr, Mohamed El Sherif ^a   Tomaru, Utano ^b   Ishizu, Akihiro ^c   Mukaida, Naofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD209 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; REGULATOR PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DIFFERENTIATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; THYMOCYTE; THYMUS; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD11; ANTIGENS, DIFFERENTIATION; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; GENE DELETION; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-2; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; RECEPTORS, CCR2; RECEPTORS, IMMUNOLOGIC; THYMOCYTES;

MURINAE; MUS;

EID: 84864003587     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041154     Document Type: Article

References (36)

1. Corthay A, Lorvik KB, Bogen B, (2011) Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?-Implications for cancer immunotherapy by adoptive T cell transfer. Scand J Immunol 73: 527-530.
2. Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B, (2009) Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells. Cancer Res 69: 5901-5907.
3. Bogen B, (1996) Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma. Eur J Immunol 26: 2671-2679.
4. Lauritzsen GF, Hofgaard PO, Schenck K, Bogen B, (1998) Clonal deletion of thymocytes as a tumor escape mechanism. Int J Cancer 78: 216-222.
5. Kyewski B, Peterson P Aire, master of many trades. Cell 140: 24-26.
6. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, et al. (2005) The cellular mechanism of Aire control of T cell tolerance. Immunity 23: 227-239.
7. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, et al. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298: 1395-1401.
8. Hogquist KA, Baldwin TA, Jameson SC, (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5: 772-782.
9. Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC, (2003) Aire regulates negative selection of organ-specific T cells. Nat Immunol 4: 350-354.
10. Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, et al. (2006) Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 7: 1092-1100.
11. Proietto AI, van Dommelen S, Zhou P, Rizzitelli A, D'Amico A, et al. (2008) Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc Natl Acad Sci U S A 105: 19869-19874.
12. Wu L, Shortman K, (2005) Heterogeneity of thymic dendritic cells. Semin Immunol 17: 304-312.
13. Kyewski B, Derbinski J, (2004) Self-representation in the thymus: an extended view. Nat Rev Immunol 4: 688-698.
14. Baba T, Nakamoto Y, Mukaida N, (2009) Crucial contribution of thymic Sirp alpha+ conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner. J Immunol 183: 3053-3063.
15. Zhang YJ, Rutledge BJ, Rollins BJ, (1994) Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem 269: 15918-15924.
16. Zhang Y, Rollins BJ, (1995) A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 15: 4851-4855.
17. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr, (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-2439.
18. Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, et al. (1997) Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A 94: 12053-12058.
19. Paessens LC, Fluitsma DM, van Kooyk Y, (2008) Haematopoietic antigen-presenting cells in the human thymic cortex: evidence for a role in selection and removal of apoptotic thymocytes. J Pathol 214: 96-103.
20. Tomaru U, Ishizu A, Murata S, Miyatake Y, Suzuki S, et al. (2009) Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex. Blood 113: 5186-5191.
21. Kawahata K, Misaki Y, Yamauchi M, Tsunekawa S, Setoguchi K, et al. (2002) Generation of CD4(+) CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 168: 4399-4405.
22. Marks BR, Nowyhed HN, Choi JY, Poholek AC, Odegard JM, et al. (2009) Thymic self-reactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat Immunol 10: 1125-1132.
23. Azakami H, Mukai A, Kato A, (2005) Role of amyloid type cross beta-structure in the formation of soluble aggregate and gel in heat-induced ovalbumin. J Agric Food Chem 53: 1254-1257.
24. Maas C, Hermeling S, Bouma B, Jiskoot W, Gebbink MF, (2007) A role for protein misfolding in immunogenicity of biopharmaceuticals. J Biol Chem 282: 2229-2236.
25. Bautista JL, Lio CW, Lathrop SK, Forbush K, Liang Y, et al. (2009) Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol 10: 610-617.
26. Lazennec G, Richmond A, (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16: 133-144.
27. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, et al. (1997) Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36: 13570-13578.
28. Paessens LC, Garcia-Vallejo JJ, Fernandes RJ, van Kooyk Y, (2007) The glycosylation of thymic microenvironments. A microscopic study using plant lectins. Immunol Lett 110: 65-73.
29. Atibalentja DF, Byersdorfer CA, Unanue ER, (2009) Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction. J Immunol 183: 7909-7918.
30. Atibalentja DF, Murphy KM, Unanue ER, (2011) Functional redundancy between thymic CD8alpha+ and Sirpalpha+ conventional dendritic cells in presentation of blood-derived lysozyme by MHC class II proteins. J Immunol 186: 1421-1431.
31. Croguennec T, Renault A, Beaufils S, Dubois JJ, Pezennec S, (2007) Interfacial properties of heat-treated ovalbumin. J Colloid Interface Sci 315: 627-636.
32. Bubanovic IV, (2003) Failure of blood-thymus barrier as a mechanism of tumor and trophoblast escape. Med Hypotheses 60: 315-320.
33. Boelaert JR, Schurgers ML, Matthys EG, Belpaire FM, Daneels RF, et al. (1989) Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int 9: 95-98.
34. Lio CW, Hsieh CS, (2008) A two-step process for thymic regulatory T cell development. Immunity 28: 100-111.
35. Burchill MA, Yang J, Vang KB, Moon JJ, Chu HH, et al. (2008) Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28: 112-121.
36. Fujii H, Baba T, Ishida Y, Kondo T, Yamagishi M, et al. (2011) Ablation of the Ccr2 gene exacerbates polyarthritis in interleukin-1 receptor antagonist-deficient mice. Arthritis Rheum 63: 96-106.